{"name":"NKMAX Co., Ltd.","slug":"nkmax-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxOdUVVZWpKU3V3Um14RV9NSTc1TnFYczA3NXJWckhxU0lZY081Wll5Y1J2NlNQS3lYeFZkUmkxcHM4amdweTlkbnlmV3JGTUx3TGpYbUdMR3lhcGdwejhzcVBBTmdUN3owSEZsb0QweGp1cXBZUFc0YVdTbkZFYk4tZDREWWx4blpzbi1mbFlCRE15MlczRFA3TmhSay11NUNSamVRdlRfSHBzVFhUNGE2LWNrcVJZUkltTEdFT1VhMXFIT25yUlZJZDlDM1RJaUt4djBlaGhWOHBTOGVha1h6OXRkSEdSNW5yZVZWc2JUQTlUeHg0YkpUaFM4Y1llTzVXTHBsakRKd3VuRmJlWnV0R3Uzbk5aaF9GV2lYdEhKSXJ5cHE2Vnhhb0taS2d2THRFUF8xa0JJMGJlZw?oc=5","date":"2025-09-09","type":"pipeline","source":"globenewswire.com","summary":"NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. - globenewswire.com","headline":"NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBHZ3AxNWpEOUo4cGl3ZUtYYzhLX21kci0tcU40SVF1azJKYXljRHduQnA5cEM2OFFlZU4tQWFVelQyaUZjTFh1ZmE2V0o2NEg0b1RsZzFpeVI4OUJTYXQ0c3Zmdzk3dnM4eFBScGNn0gFyQVVfeXFMTXdHSE9Yal8yblBjS05heVhSWTNXRUx2MUdjMHJjamRla2h4dmhQMW5FTVdNSXhmcFRtZlN1TU0ycWoySklfUUVVTmJSWmVxNmNod0g0TUdscWpwNVBEbFcyd2kwWWFTdXpFa2R0N1NXTjJ3?oc=5","date":"2024-04-11","type":"pipeline","source":"koreabiomed.com","summary":"NKMAX to challenge delisting decision by Korea Exchange - koreabiomed.com","headline":"NKMAX to challenge delisting decision by Korea Exchange","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9OVE9fRkNFQU5BTG9OcTVMR3RMeTZ6UHZaQllSWElLbWlTdTYtT2w5aTQwZjVTdG5hWEJjQXpYU2g2bEk0dmlIMXlBZmRndzA1RmJGWW1na0FMTlpmX1d2WDVaZXBCUkhIbFRIM253?oc=5","date":"2024-03-18","type":"pipeline","source":"KED Global","summary":"Reversing age possible in a decade: Harvard Prof. David Sinclair - KED Global","headline":"Reversing age possible in a decade: Harvard Prof. David Sinclair","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE13Ql9tRkZ0RkluN1Y5eG5fM2c3YkVoazBhWGJRNmVTRXg2bkZpeWtVamFTNjNvYnpGN3M2SHM5OTBfSmNKXzdaUU5sdjZhVzYtSzU1SDlUQlByLXc3M2c0S2NxWklQaEN5NzdWb19B?oc=5","date":"2023-03-27","type":"pipeline","source":"KED Global","summary":"S.Korea's microneedle maker Raphas to enter US market - KED Global","headline":"S.Korea's microneedle maker Raphas to enter US market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBvXy1iM2lfTXJidFlpN2kyYzlrS3RGMVhyNFk5bGZWa2N0SmtaWHc0dl9nX0xMMjlRWnBOWV95d2I2V1hHazFKcDFPczNVUnBlMkJrZnZ1dUZZRVBOWjgwY2tUWk00bE84ajN1OGh3?oc=5","date":"2023-03-21","type":"pipeline","source":"KED Global","summary":"Korea’s Micro Digital to supply bioreactors to major US firm - KED Global","headline":"Korea’s Micro Digital to supply bioreactors to major US firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9qaUQtN1d4Q1lpUm5Nbmx5THI2QmhzMHNYU01JcjdnclZQWUVCRWVpay1XWHkxT2dRMENXc3A1OUI0b1p4ZzI1M3AzSDMxUHpDVDZ1VDl6MEJIX3p0X09LVnhRdnB0cEY0NDViM1JR?oc=5","date":"2023-03-14","type":"pipeline","source":"KED Global","summary":"S.Korean biotech NKMax’s unit aims for US IPO - KED Global","headline":"S.Korean biotech NKMax’s unit aims for US IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxONDB0aG5zcTZ0QU1TLXhaVHprWFdHOEVKaUd2Y0s4TnNoc3QtUENmNkpJNWQ5YWZIS0Z3OHhiNHVDN1g3NTRKcUo0YXhMVURxanF5bW5BRTVLZVpmX0ZmMmFsQlcxOHV2TGJqcHZfY1FvTDJHSDdMVUd3RTdKdFJ1SXN6OTE2cVJvZ1RUTEU0Tld0ZkM1WHF6bHBEZUhadDJQMnc?oc=5","date":"2019-12-17","type":"pipeline","source":"BioWorld News","summary":"Nkmax America secures $11M in seed round, eyes NASDAQ listing - BioWorld News","headline":"Nkmax America secures $11M in seed round, eyes NASDAQ listing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}